##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 5 (2025)

Intrapartum antibiotic prophylaxis for Streptococcal B colonisation: a cross-sectional study of hospital internal protocols in Switzerland

Cite this as:
Swiss Med Wkly. 2025;155:4297
Published
03.05.2025

Summary

STUDY AIMS: Streptococcus agalacticae is a pathogen associated with maternal and neonatal morbidity and mortality. The current gold standard for preventing neonatal sepsis is the intrapartum antibiotic prophylaxis (IAP) of Streptococcus agalacticae-positive mothers. Antimicrobial resistance is on the rise and increasingly threatens public health. Therefore, the responsible use of antibiotics is critical. Switzerland lacks unified IAP guidelines. IAP management varies by obstetric ward and is based on various national and international guidelines. This study aimed to gain an overview of the variability of existing internal protocols for IAP for Streptococcus agalacticae in Swiss obstetrics wards.

METHOD: In March and April 2024, all identified obstetric wards in Switzerland were contacted and invited to submit their internal protocols so that they could be analysed for the choice of antibiotics for IAP, the referenced literature supporting their protocols and the professions involved in their development.

RESULTS: Of 87 departments contacted, 43 (49%) shared their protocols. Three β-lactam antibiotics were identified as the first choice: penicillin G (56%, n = 24), amoxicillin (28%, n = 12) and co-amoxicillin (9%, n = 4). In 19% of the protocols (n = 8), there was no distinction between mild or severe allergy to penicillin derivatives. In this group (n = 8), 75% (n = 6) administered clindamycin as the second choice, with 50% (n = 3 of 6) offering vancomycin as an alternative in cases of known clindamycin resistance or allergy. In the group with allergy severity classification (n = 35), first- and second-generation cephalosporins were preferred for mild penicillin allergy: 71% (n = 25) used cefazolin, 26% (n = 9) used cefuroxime and erythromycin was mentioned by n = 1. In 21 of the 33 received protocols with references, Expert Letter No. 19 from the Swiss Society of Gynaecology and Obstetrics (SGGG) was referenced, making up 64 % of the used literature. This was followed by other literature (58 %, n = 19) and the revised guidelines of the Swiss Society of Neonatology in collaboration with the Paediatric Infectious Disease Group Switzerland (PIGS) (30 %, n = 10). Mostly gynaecologists (90%; n = 28 of 31) were involved as authors of internal protocols. Neonatologists were not mentioned by any.

CONCLUSION: Our study highlights that the management of intrapartum antibiotic prophylaxis is heterogeneous, and antimicrobial stewardship is lacking in most Swiss obstetric wards. In terms of literature, German-speaking wards in Switzerland are more orientated towards German-speaking neighbouring countries than French- and Italian-speaking wards. There is a need to enhance interdisciplinarity in the development of internal protocols and to create a joint national guideline among professional societies.

References

  1. Russell NJ, Seale AC, O’Driscoll M, O’Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al.; GBS Maternal Colonization Investigator Group. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses. Clin Infect Dis. 2017 Nov;65 suppl_2:S100–11. doi: https://doi.org/10.1093/cid/cix658
  2. Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly. 2013 Mar;143(1314):w13778. doi: https://doi.org/10.4414/smw.2013.13778
  3. Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, et al. Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children. Clin Infect Dis. 2017 Nov;65 suppl_2:S200–19. doi: https://doi.org/10.1093/cid/cix664
  4. World Health Organization. Defeating Meningitis by 2030. A Global Road MAP. 2021 Jun; Available from: https://iris.who.int/bitstream/handle/10665/342010/9789240026407-eng.pdf?sequence=1
  5. Giannoni E, Berger C, Stocker M, Agyeman P, Posfay-Barbe KM, Heininger U, et al.; Swiss Pediatric Sepsis Study Group. Incidence and Outcome of Group B Streptococcal Sepsis in Infants in Switzerland. Pediatr Infect Dis J. 2016 Feb;35(2):222–4. doi: https://doi.org/10.1097/INF.0000000000000974
  6. Paul P, Gonçalves BP, Le Doare K, Lawn JE. 20 million pregnant women with group B streptococcus carriage: consequences, challenges, and opportunities for prevention. Curr Opin Pediatr. 2023 Apr;35(2):223–30. doi: https://doi.org/10.1097/MOP.0000000000001223
  7. Surbek D, Henle-Gross A, Seydoux J, Honegger C, Irion O, Drack G. Prophylaxe der Early-onset-Neugeborenensepsis durch Streptokokken der Gruppe B (aktualisierte Version, 19.7.2012). Available from: https://www.sggg.ch/fileadmin/user_upload/Dokumente/3_Fachinformationen/1_Expertenbriefe/De/19_Prophylaxe_Neugeborenensepsis_Streptokokken_2012.pdf
  8. Berger C, Giannoni E, McDougall J, Stocker M. Empfehlungen zur Prävention und Therapie von Termin- und knapp frühgeborenen Kindern (>34 SSW) mit erhöhtem Risiko einer perinatalen bakteriellen Infektion (early-onset Sepsis). Revidierte Empfehlungen der Schweizerischen Gesellschaft für Neonatologie in Zusammenarbeit mit der Pädiatrischen Infektiologiegruppe (PIGS). Paediatrica. 2013;24(1):11–3. Available from: https://www.paediatrieschweiz.ch/empfehlungen-zur-pravention-und-therapie-von-termin-und-knapp-fruh-geborenen-kindern-34-ssw-mit-erhohtem-risiko-einer-perinatalen-bakteriellen-infektion-early-onset-sepsis/
  9. Amylidi-Mohr S, Ardabili S, Hamza A, Honegger Ch, Kidszun A, Martinez de Tejada B, Stahel M, Surbek D. Clinical Practice Recommendations No 86 - Prophylaxis of early-onset neonatal sepsis caused by groub B streptococci. Swiss Academy for Maternal Fetal Medicine (AFMM); 2024 May. Available from: Amylidi-Mohr S, Ardabili S, Hamza A, Honegger Ch, Kidszun A, Martinez de Tejada B, Stahel M, Surbek D. Clinical Practice Recommendations No 86 - Prophylaxis of early-onset neonatal sepsis caused by groub B streptococci. Swiss Academy for Maternal Fetal Medicine (AFMM); 2024 May.
  10. Stocker M, Rosa-Mangeret F, Agyeman PK, McDougall J, Berger C, Giannoni E. Management of neonates at risk of early onset sepsis: a probability-based approach and recent literature appraisal : Update of the Swiss national guideline of the Swiss Society of Neonatology and the Pediatric Infectious Disease Group Switzerland. Eur J Pediatr. 2024 Dec;183(12):5517–29. doi: https://doi.org/10.1007/s00431-024-05811-0
  11. Eidgenossenschaft S. Strategie Antibiotikaresistenzen Schweiz [Internet]. 2015. Available from: https://www.star.admin.ch/dam/star/de/dokumente/strategiebericht-star.pdf.download.pdf/strategiebericht-star-de.pdf
  12. Giannoni E, Dimopoulou V, Klingenberg C, Navér L, Nordberg V, Berardi A, et al. Analysis of Antibiotic Exposure and Early-Onset Neonatal Sepsis in Europe, North America, and Australia. 2022 Nov 1; Available from: https://boris-portal.unibe.ch/handle/20.500.12422/115558
  13. BAG B für G. Strategie Antibiotikaresistenzen Bereich Mensch. Available from: https://www.bag.admin.ch/bag/de/home/strategie-und-politik/nationale-gesundheitsstrategien/strategie-antibiotikaresistenzen-schweiz.html
  14. Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiol Spectr. 2019 Mar;7(2):7.2.17. 10.1128/microbiolspec.gpp3-0007-2018 doi: https://doi.org/10.1128/microbiolspec.GPP3-0007-2018
  15. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al.; Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022 Feb;399(10325):629–55. doi: https://doi.org/10.1016/S0140-6736(21)02724-0
  16. WHO Bacterial Priority Pathogens List 2024: Bacterial Pathogens of Public Health Importance, to Guide Research, Development, and Strategies to Prevent and Control Antimicrobial Resistance. 1st ed. Geneva: World Health Organization; 2024. 1 p. Available from: https://www.who.int/publications/i/item/9789240093461
  17. OECD. Embracing a One Health Framework to Fight Antimicrobial Resistance. OECD; 2023. (OECD Health Policy Studies). Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/embracing-a-one-health-framework-to-fight-antimicrobial-resistance_ce44c755-en
  18. World leaders commit to decisive action on antimicrobial resistance. Available from: https://www.who.int/news-room/26-09-2024-world-leaders-commit-to-decisive-action-on-antimicrobial-resistance
  19. Rüefli C. Formative Evaluation der Umsetzung der Strategie Antibiotikaresistenzen Schweiz (StAR). Zusammenfassung. Bern: Bundesamt für Gesundheit; 2023., Available from https://www.bag.admin.ch/dam/bag/de/dokumente/e-f/evalber-mt/2023-formative-evaluation-umsetzung-star-zusammenfassung.pdf.download.pdf/2023-zusammenfassung-formative-evaluation-umsetzung-star-d.pdf
  20. Projek-Partnerschaft StAR-3. Leitfaden für die Initiierung eines Antimicrobial Stewardship Programms (ASP). 2024 Available from: https://swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/3_Umsetzung_StAR/StAR_3/Handbook_Deutsch/ASP_Starting_Shortguide_Deutsch.pdf
  21. Geburtsspitäler und Kliniken in der Schweiz. Available from: https://www.geburtsspital.ch/
  22. BAG B für G. Spital suchen. Available from: https://www.bag.admin.ch/bag/de/home/zahlen-und-statistiken/zahlen-fakten-zu-spitaelern/spital-suchen.html
  23. National institute for Health and Care Excellence [NICE]. Neonatal infection: antibiotics for prevention and treatment - NICE guieline 195. 2021; Available from: https://www.nice.org.uk/guidance/ng195
  24. Bielicki J, Berger C, Bornand D, Huttner B, Kuster SP, Senn L, et al. SwissASP - framework conditions. Swissnoso SwissASP working group; 2020. Available from: https://www.swissnoso.ch/fileadmin/swissnoso/Dokumente/5_Forschung_und_Entwicklung/9_AB_Stewardship/201119_SwissASP_framework_conditions_en.pdf
  25. Herting E, Härtel C, Franz A, Kehl S, Gille C, Doubek K, et al. S2k-Leitlinie 024/20 Prophylaxe der Neugeborenensepsis (frühe Form) durch Streptokokken der Gruppe B. AWMF Online. 2016; Available from: https://register.awmf.org/assets/guidelines/024-020l_S2k_Prophylaxe_Neugeborenensepsis_Streptokokken_2016-04-abgelaufen.pdf
  26. Royal College of Obstetricians and Gynaecologists. Prevention of Early‐onset Neonatal Group B Streptococcal Disease: Green‐top Guideline No. 36. BJOG Int J Obstet Gynaecol. 2017 Nov;124(12). Available from: https://obgyn.onlinelibrary.wiley.com/doi/10.1111/1471-0528.14821
  27. The Amercian college of Obstetricians and Gynecologists. Committee Opinion Early-Onset Group B Streptococcal Disease. Nr 797. 2020; Available from: https://www.acog.org/clinical/clinical-guidance/committee-opinion/articles/2020/02/prevention-of-group-b-streptococcal-early-onset-disease-in-newborns
  28. Winteler C, Ardabili S, Hodel M, Stocker M. A systematic review of Perinatal Antibiotic Stewardship - where we are, where to go? J Perinatol Off J Calif Perinat Assoc. 2025 Jan 20;
  29. Miselli F, Cuoghi Costantini R, Creti R, Sforza F, Fanaro S, Ciccia M, et al. Escherichia coli Is Overtaking Group B Streptococcus in Early-Onset Neonatal Sepsis. Microorganisms. 2022 Sep;10(10):1878. doi: https://doi.org/10.3390/microorganisms10101878
  30. Guide A. Available from: https://guide.anresis.ch/human-bacteria?filters=[%22filter-gramStain-2%22,%22mo-17%22]
  31. Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2013 Dec;2013(12):CD001058. doi: https://doi.org/10.1002/14651858.CD001058.pub3
  32. Shenoy ES, Macy E, Rowe T, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019 Jan;321(2):188–99. doi: https://doi.org/10.1001/jama.2018.19283
  33. StAR-3. Available from: https://swissnoso.ch/forschung-entwicklung/umsetzung-star/star-3-antimicrobial-stewardship-programs-for-swiss-hospitals
  34. Osthoff M, Bielicki J, Widmer AF, For Swissnoso. Evaluation of existing and desired antimicrobial stewardship activities and strategies in Swiss hospitals. Swiss Med Wkly. 2017 Oct;147(4142):w14512.
  35. One Health Aktionsplan 2024-2027. Bundesamt für Gesundheit BAG, Bundesamt für Lebenmittelsicherheit und Veterinärwesen BLV, Bundesamt für Landwirtschaft BLW, Bundesamt für Umwelt BAFU; 2024. Available from: https://www.star.admin.ch/dam/star/de/dokumente/one-health-aktionsplan-star.pdf.download.pdf/One-Health-Aktionsplan-StAR-de-v7.pdf